Fig. 3: Emerging therapeutic targets from the immune and inflammasome pathway in MDS.
From: Therapeutic targeting of the inflammasome in myeloid malignancies
The figure depicts the various biomolecules from the inflammasome pathway that are targeted by the novel therapeutic agents in MDS and AML.
